This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-496 | ABCA13 | 0.55 | 0.60838 | 1.28 | 0.26041 | miRanda | -0.29 | 0.0197 | NA | |
2 | hsa-miR-543 | ABCA13 | -0.29 | 0.65642 | 1.28 | 0.26041 | miRanda | -0.44 | 0.00099 | NA | |
3 | hsa-miR-496 | ACOT9 | 0.55 | 0.60838 | -0.92 | 0.7285 | miRanda | -0.22 | 0 | NA | |
4 | hsa-miR-496 | ACSM1 | 0.55 | 0.60838 | -0.69 | 0.40934 | miRanda | -0.31 | 0.00051 | NA | |
5 | hsa-miR-543 | ACSM3 | -0.29 | 0.65642 | -0.23 | 0.89918 | miRanda | -0.19 | 0.02145 | NA | |
6 | hsa-miR-543 | ACSS1 | -0.29 | 0.65642 | -1.32 | 0.64713 | miRanda | -0.19 | 0.00532 | NA | |
7 | hsa-miR-543 | ACTG2 | -0.29 | 0.65642 | 0.03 | 0.98974 | miRanda | -0.36 | 0.01279 | NA | |
8 | hsa-miR-496 | ACTR3 | 0.55 | 0.60838 | -0.76 | 0.84655 | miRanda | -0.1 | 0.00028 | NA | |
9 | hsa-miR-496 | ADAM28 | 0.55 | 0.60838 | -1.46 | 0.61423 | miRanda | -0.43 | 1.0E-5 | NA | |
10 | hsa-miR-543 | ADAM28 | -0.29 | 0.65642 | -1.46 | 0.61423 | miRanda | -0.52 | 0 | NA | |
11 | hsa-miR-543 | ADAM9 | -0.29 | 0.65642 | -0.36 | 0.92876 | miRanda | -0.2 | 0.00126 | NA | |
12 | hsa-miR-496 | ADAMTS6 | 0.55 | 0.60838 | -0.6 | 0.59783 | miRanda | -0.23 | 0.00039 | NA | |
13 | hsa-miR-496 | ADAMTSL5 | 0.55 | 0.60838 | 0.17 | 0.90384 | miRanda | -0.44 | 0 | NA | |
14 | hsa-miR-543 | ADAT2 | -0.29 | 0.65642 | -0.42 | 0.76827 | miRanda | -0.11 | 0.01486 | NA | |
15 | hsa-miR-543 | ADD3 | -0.29 | 0.65642 | -0.44 | 0.90001 | miRanda | -0.13 | 0.0027 | NA | |
16 | hsa-miR-496 | ADORA2B | 0.55 | 0.60838 | 1.45 | 0.33396 | miRanda | -0.15 | 0.03225 | NA | |
17 | hsa-miR-543 | ADSS | -0.29 | 0.65642 | 0.2 | 0.94898 | miRanda | -0.13 | 2.0E-5 | NA | |
18 | hsa-miR-543 | AFAP1L2 | -0.29 | 0.65642 | -0.63 | 0.81741 | miRanda | -0.23 | 0.00015 | NA | |
19 | hsa-miR-496 | AGMAT | 0.55 | 0.60838 | 0.11 | 0.91872 | miRanda | -0.16 | 0.03277 | NA | |
20 | hsa-miR-543 | AGR2 | -0.29 | 0.65642 | 4.07 | 0.36748 | miRanda | -0.81 | 0 | NA | |
21 | hsa-miR-543 | AGR3 | -0.29 | 0.65642 | 1.7 | 0.52011 | miRanda | -0.69 | 1.0E-5 | NA | |
22 | hsa-miR-543 | AHNAK | -0.29 | 0.65642 | -0.09 | 0.98554 | miRanda | -0.15 | 0.00219 | NA | |
23 | hsa-miR-375 | AHR | 3.94 | 0.60651 | -0.01 | 0.99721 | miRanda | -0.1 | 0.00054 | NA | |
24 | hsa-miR-496 | AHR | 0.55 | 0.60838 | -0.01 | 0.99721 | miRanda | -0.13 | 0.00786 | NA | |
25 | hsa-miR-543 | AHR | -0.29 | 0.65642 | -0.01 | 0.99721 | miRanda | -0.2 | 0.00019 | NA | |
26 | hsa-miR-543 | AIM1 | -0.29 | 0.65642 | -1.12 | 0.69647 | miRanda | -0.21 | 0.00586 | NA | |
27 | hsa-miR-543 | AIM1L | -0.29 | 0.65642 | 1.83 | 0.35987 | miRanda | -0.73 | 0 | NA | |
28 | hsa-miR-543 | AKAP5 | -0.29 | 0.65642 | -1.34 | 0.20418 | miRanda | -0.13 | 0.02031 | NA | |
29 | hsa-miR-496 | ALG3 | 0.55 | 0.60838 | 0.42 | 0.88028 | miRanda | -0.17 | 0 | NA | |
30 | hsa-miR-543 | ANO6 | -0.29 | 0.65642 | -0.6 | 0.86077 | miRanda | -0.11 | 0.01691 | NA | |
31 | hsa-miR-543 | ANTXR1 | -0.29 | 0.65642 | -0.72 | 0.85999 | miRanda | -0.18 | 0.03347 | NA | |
32 | hsa-miR-543 | ANXA2P3 | -0.29 | 0.65642 | -1.19 | 0.20049 | miRanda | -0.23 | 0.00749 | NA | |
33 | hsa-miR-496 | ANXA4 | 0.55 | 0.60838 | -0.24 | 0.95893 | miRanda | -0.23 | 0.00158 | NA | |
34 | hsa-miR-496 | APBB1IP | 0.55 | 0.60838 | -2.51 | 0.20132 | miRanda | -0.17 | 0.03618 | NA | |
35 | hsa-miR-543 | AQP9 | -0.29 | 0.65642 | -2.92 | 0.0592 | miRanda | -0.31 | 0.00705 | NA | |
36 | hsa-miR-375 | ARAP2 | 3.94 | 0.60651 | -0.75 | 0.76433 | miRanda | -0.13 | 3.0E-5 | NA | |
37 | hsa-miR-496 | ARHGAP11A | 0.55 | 0.60838 | 0.46 | 0.80083 | miRanda | -0.17 | 0.00062 | NA | |
38 | hsa-miR-543 | ARHGAP11B | -0.29 | 0.65642 | -0.29 | 0.66969 | miRanda | -0.19 | 0.01267 | NA | |
39 | hsa-miR-543 | ARHGAP12 | -0.29 | 0.65642 | 0.06 | 0.98334 | miRanda | -0.12 | 0.00205 | NA | |
40 | hsa-miR-496 | ARHGAP27 | 0.55 | 0.60838 | -0.4 | 0.90004 | miRanda | -0.28 | 0 | NA | |
41 | hsa-miR-543 | ARHGAP32 | -0.29 | 0.65642 | 0.77 | 0.80338 | miRanda | -0.19 | 0.00013 | NA | |
42 | hsa-miR-543 | ARHGAP6 | -0.29 | 0.65642 | 0.01 | 0.99291 | miRanda | -0.17 | 0.00954 | NA | |
43 | hsa-miR-375 | ARHGDIB | 3.94 | 0.60651 | -1.53 | 0.67706 | miRanda | -0.1 | 0.00041 | NA | |
44 | hsa-miR-543 | ARHGEF2 | -0.29 | 0.65642 | -0.51 | 0.87953 | miRanda | -0.19 | 0 | NA | |
45 | hsa-miR-375 | ARL14 | 3.94 | 0.60651 | 0.61 | 0.81063 | miRanda | -0.23 | 0.00681 | NA | |
46 | hsa-miR-543 | ARL14 | -0.29 | 0.65642 | 0.61 | 0.81063 | miRanda | -0.91 | 0 | NA | |
47 | hsa-miR-543 | ARMC10 | -0.29 | 0.65642 | 0.08 | 0.97417 | miRanda | -0.11 | 5.0E-5 | NA | |
48 | hsa-miR-543 | ARPC1B | -0.29 | 0.65642 | -0.87 | 0.83457 | miRanda | -0.15 | 0.00019 | NA | |
49 | hsa-miR-496 | ASAP2 | 0.55 | 0.60838 | 0.83 | 0.79826 | miRanda | -0.11 | 0.0381 | NA | |
50 | hsa-miR-543 | ASAP2 | -0.29 | 0.65642 | 0.83 | 0.79826 | miRanda | -0.21 | 9.0E-5 | NA | |
51 | hsa-miR-543 | ASF1B | -0.29 | 0.65642 | 0.26 | 0.89226 | miRanda | -0.26 | 5.0E-5 | NA | |
52 | hsa-miR-543 | ASPH | -0.29 | 0.65642 | 0.46 | 0.90891 | miRanda | -0.17 | 0.00504 | NA | |
53 | hsa-miR-543 | ASPN | -0.29 | 0.65642 | 0.21 | 0.94844 | miRanda | -0.24 | 0.01215 | NA | |
54 | hsa-miR-543 | ATF7IP2 | -0.29 | 0.65642 | -1.06 | 0.53248 | miRanda | -0.26 | 4.0E-5 | NA | |
55 | hsa-miR-375 | ATP10A | 3.94 | 0.60651 | -0.6 | 0.77679 | miRanda | -0.16 | 1.0E-5 | NA | |
56 | hsa-miR-543 | ATP10A | -0.29 | 0.65642 | -0.6 | 0.77679 | miRanda | -0.15 | 0.02231 | NA | |
57 | hsa-miR-496 | ATP10B | 0.55 | 0.60838 | 0.12 | 0.9634 | miRanda | -0.54 | 0.00033 | NA | |
58 | hsa-miR-543 | ATP11B | -0.29 | 0.65642 | -0.31 | 0.92367 | miRanda | -0.14 | 0.00019 | NA | |
59 | hsa-miR-543 | ATP6V0D2 | -0.29 | 0.65642 | -2.18 | 0.00523 | miRanda | -0.3 | 0.00118 | NA | |
60 | hsa-miR-496 | AVL9 | 0.55 | 0.60838 | 0.07 | 0.97309 | miRanda | -0.11 | 0.00245 | NA | |
61 | hsa-miR-543 | AVL9 | -0.29 | 0.65642 | 0.07 | 0.97309 | miRanda | -0.14 | 0.00014 | NA | |
62 | hsa-miR-543 | B2M | -0.29 | 0.65642 | -0.63 | 0.91369 | miRanda | -0.13 | 0.00087 | NA | |
63 | hsa-miR-543 | B3GNT5 | -0.29 | 0.65642 | 0.43 | 0.87244 | miRanda | -0.17 | 0.00292 | NA | |
64 | hsa-miR-543 | B3GNT6 | -0.29 | 0.65642 | 0.67 | 0.72571 | miRanda | -0.87 | 0.00015 | NA | |
65 | hsa-miR-496 | BAIAP2L1 | 0.55 | 0.60838 | 1.27 | 0.71967 | miRanda | -0.15 | 0.02439 | NA | |
66 | hsa-miR-543 | BARX2 | -0.29 | 0.65642 | -0.6 | 0.77231 | miRanda | -0.47 | 9.0E-5 | NA | |
67 | hsa-miR-543 | BAZ1A | -0.29 | 0.65642 | -0.9 | 0.7528 | miRanda | -0.15 | 0.00065 | NA | |
68 | hsa-miR-375 | BCL11B | 3.94 | 0.60651 | -1.34 | 0.42572 | miRanda | -0.11 | 0.01666 | NA | |
69 | hsa-miR-375 | BCL2L14 | 3.94 | 0.60651 | -0.38 | 0.81716 | miRanda | -0.2 | 0.00408 | NA | |
70 | hsa-miR-496 | BCL2L14 | 0.55 | 0.60838 | -0.38 | 0.81716 | miRanda | -0.69 | 0 | NA | |
71 | hsa-miR-543 | BCL2L14 | -0.29 | 0.65642 | -0.38 | 0.81716 | miRanda | -0.76 | 0 | NA | |
72 | hsa-miR-375 | BCL6 | 3.94 | 0.60651 | -0.92 | 0.7625 | miRanda | -0.14 | 0 | NA | |
73 | hsa-miR-543 | BCL6 | -0.29 | 0.65642 | -0.92 | 0.7625 | miRanda | -0.12 | 0.01083 | NA | |
74 | hsa-miR-543 | BDNF | -0.29 | 0.65642 | 0.42 | 0.57837 | miRanda | -0.18 | 0.03626 | NA | |
75 | hsa-miR-543 | BHLHE40 | -0.29 | 0.65642 | 0.24 | 0.95761 | miRanda | -0.16 | 0.01932 | NA | |
76 | hsa-miR-543 | BID | -0.29 | 0.65642 | -0.12 | 0.96368 | miRanda | -0.1 | 0.00802 | NA | |
77 | hsa-miR-496 | BIN3 | 0.55 | 0.60838 | 0.11 | 0.96472 | miRanda | -0.1 | 0.00273 | NA | |
78 | hsa-miR-375 | BIRC5 | 3.94 | 0.60651 | 0.4 | 0.79598 | miRanda | -0.27 | 0 | NA | |
79 | hsa-miR-543 | BRI3 | -0.29 | 0.65642 | -0.14 | 0.96667 | miRanda | -0.12 | 0.00056 | NA | |
80 | hsa-miR-496 | BTNL3 | 0.55 | 0.60838 | -1.79 | 0.37933 | miRanda | -0.48 | 0.02633 | NA | |
81 | hsa-miR-543 | BUB1 | -0.29 | 0.65642 | -0.03 | 0.98544 | miRanda | -0.31 | 9.0E-5 | NA | |
82 | hsa-miR-543 | BUB1B | -0.29 | 0.65642 | 0.31 | 0.84796 | miRanda | -0.21 | 0.00376 | NA | |
83 | hsa-miR-496 | BZW2 | 0.55 | 0.60838 | 0.15 | 0.96074 | miRanda | -0.15 | 1.0E-5 | NA | |
84 | hsa-miR-543 | BZW2 | -0.29 | 0.65642 | 0.15 | 0.96074 | miRanda | -0.17 | 1.0E-5 | NA | |
85 | hsa-miR-543 | CAB39 | -0.29 | 0.65642 | -0.23 | 0.94628 | miRanda | -0.11 | 0.00016 | NA | |
86 | hsa-miR-543 | CAMK2N1 | -0.29 | 0.65642 | 1.67 | 0.64627 | miRanda | -0.15 | 0.00572 | NA | |
87 | hsa-miR-543 | CAP1 | -0.29 | 0.65642 | -0.58 | 0.89508 | miRanda | -0.13 | 0.00033 | NA | |
88 | hsa-miR-496 | CAPG | 0.55 | 0.60838 | -1.57 | 0.69914 | miRanda | -0.46 | 0 | NA | |
89 | hsa-miR-496 | CARD14 | 0.55 | 0.60838 | 0.14 | 0.87137 | miRanda | -0.24 | 0.00091 | NA | |
90 | hsa-miR-543 | CARD14 | -0.29 | 0.65642 | 0.14 | 0.87137 | miRanda | -0.33 | 2.0E-5 | NA | |
91 | hsa-miR-496 | CASP4 | 0.55 | 0.60838 | -0.96 | 0.75012 | miRanda | -0.2 | 0 | NA | |
92 | hsa-miR-543 | CASP4 | -0.29 | 0.65642 | -0.96 | 0.75012 | miRanda | -0.2 | 0 | NA | |
93 | hsa-miR-543 | CASP7 | -0.29 | 0.65642 | -0.23 | 0.93464 | miRanda | -0.16 | 6.0E-5 | NA | |
94 | hsa-miR-543 | CASP8 | -0.29 | 0.65642 | -1.07 | 0.67507 | miRanda | -0.23 | 1.0E-5 | NA | |
95 | hsa-miR-543 | CAST | -0.29 | 0.65642 | -0 | 0.99966 | miRanda | -0.13 | 0.00026 | NA | |
96 | hsa-miR-543 | CBLB | -0.29 | 0.65642 | -0.67 | 0.79551 | miRanda | -0.11 | 0.00076 | NA | |
97 | hsa-miR-496 | CCDC84 | 0.55 | 0.60838 | -0.16 | 0.91539 | miRanda | -0.12 | 0.01041 | NA | |
98 | hsa-miR-543 | CCDC88C | -0.29 | 0.65642 | -1.33 | 0.61736 | miRanda | -0.25 | 4.0E-5 | NA | |
99 | hsa-miR-543 | CCK | -0.29 | 0.65642 | 2.35 | 0.15308 | miRanda | -0.78 | 5.0E-5 | NA | |
100 | hsa-miR-543 | CCL11 | -0.29 | 0.65642 | -0.72 | 0.509 | miRanda | -0.32 | 0.00456 | NA | |
101 | hsa-miR-496 | CCL20 | 0.55 | 0.60838 | -0.66 | 0.76681 | miRanda | -0.62 | 1.0E-5 | NA | |
102 | hsa-miR-543 | CCL22 | -0.29 | 0.65642 | -1.79 | 0.28612 | miRanda | -0.42 | 0.00052 | NA | |
103 | hsa-miR-496 | CCL28 | 0.55 | 0.60838 | -2.18 | 0.2159 | miRanda | -0.34 | 0.00093 | NA | |
104 | hsa-miR-496 | CCNB1 | 0.55 | 0.60838 | 0.85 | 0.7071 | miRanda | -0.13 | 0.0144 | NA | |
105 | hsa-miR-543 | CCNB1 | -0.29 | 0.65642 | 0.85 | 0.7071 | miRanda | -0.14 | 0.01214 | NA | |
106 | hsa-miR-543 | CCNF | -0.29 | 0.65642 | 0.14 | 0.93342 | miRanda | -0.14 | 0.00354 | NA | |
107 | hsa-miR-543 | CCNI2 | -0.29 | 0.65642 | -0.19 | 0.84244 | miRanda | -0.34 | 1.0E-5 | NA | |
108 | hsa-miR-496 | CD2AP | 0.55 | 0.60838 | 0.05 | 0.98919 | miRanda | -0.1 | 0.01373 | NA | |
109 | hsa-miR-543 | CD2AP | -0.29 | 0.65642 | 0.05 | 0.98919 | miRanda | -0.19 | 3.0E-5 | NA | |
110 | hsa-miR-543 | CD300LF | -0.29 | 0.65642 | -2.84 | 0.04531 | miRanda | -0.18 | 0.04524 | NA | |
111 | hsa-miR-543 | CD55 | -0.29 | 0.65642 | 0.55 | 0.89013 | miRanda | -0.3 | 8.0E-5 | NA | |
112 | hsa-miR-496 | CD72 | 0.55 | 0.60838 | -2.48 | 0.10288 | miRanda | -0.17 | 0.03696 | NA | |
113 | hsa-miR-496 | CDCA7 | 0.55 | 0.60838 | -0.05 | 0.98348 | miRanda | -0.66 | 0 | NA | |
114 | hsa-miR-543 | CDCA7 | -0.29 | 0.65642 | -0.05 | 0.98348 | miRanda | -0.7 | 0 | NA | |
115 | hsa-miR-496 | CDCP1 | 0.55 | 0.60838 | 1.44 | 0.67986 | miRanda | -0.15 | 0.01447 | NA | |
116 | hsa-miR-543 | CDH11 | -0.29 | 0.65642 | -1.41 | 0.68344 | miRanda | -0.28 | 0.0034 | NA | |
117 | hsa-miR-543 | CDH17 | -0.29 | 0.65642 | 1.99 | 0.44607 | miRanda | -0.46 | 0.00539 | NA | |
118 | hsa-miR-543 | CDHR5 | -0.29 | 0.65642 | 2.66 | 0.31323 | miRanda | -0.47 | 0.0013 | NA | |
119 | hsa-miR-375 | CDK1 | 3.94 | 0.60651 | 0.33 | 0.87769 | miRanda | -0.22 | 0 | NA | |
120 | hsa-miR-496 | CDK1 | 0.55 | 0.60838 | 0.33 | 0.87769 | miRanda | -0.27 | 3.0E-5 | NA | |
121 | hsa-miR-543 | CDK1 | -0.29 | 0.65642 | 0.33 | 0.87769 | miRanda | -0.3 | 2.0E-5 | NA | |
122 | hsa-miR-375 | CDK2 | 3.94 | 0.60651 | -0.46 | 0.84811 | miRanda | -0.12 | 0 | NA | |
123 | hsa-miR-496 | CENPE | 0.55 | 0.60838 | 0.08 | 0.95983 | miRanda | -0.21 | 0.00136 | NA | |
124 | hsa-miR-543 | CENPE | -0.29 | 0.65642 | 0.08 | 0.95983 | miRanda | -0.21 | 0.00363 | NA | |
125 | hsa-miR-543 | CENPI | -0.29 | 0.65642 | 0.31 | 0.67033 | miRanda | -0.27 | 0.0015 | NA | |
126 | hsa-miR-543 | CENPW | -0.29 | 0.65642 | 0 | 0.99953 | miRanda | -0.15 | 0.00956 | NA | |
127 | hsa-miR-543 | CEP55 | -0.29 | 0.65642 | 0.07 | 0.97056 | miRanda | -0.42 | 0 | NA | |
128 | hsa-miR-543 | CES2 | -0.29 | 0.65642 | 0.48 | 0.88344 | miRanda | -0.11 | 0.04098 | NA | |
129 | hsa-miR-543 | CFL1 | -0.29 | 0.65642 | -0.37 | 0.94146 | miRanda | -0.12 | 0.00013 | NA | |
130 | hsa-miR-543 | CFLAR | -0.29 | 0.65642 | -0.66 | 0.83109 | miRanda | -0.15 | 6.0E-5 | NA | |
131 | hsa-miR-543 | CFTR | -0.29 | 0.65642 | -1.12 | 0.77039 | miRanda | -0.65 | 0.00222 | NA | |
132 | hsa-miR-543 | CGN | -0.29 | 0.65642 | 2.1 | 0.56692 | miRanda | -0.33 | 6.0E-5 | NA | |
133 | hsa-miR-543 | CHML | -0.29 | 0.65642 | -0.35 | 0.86584 | miRanda | -0.15 | 0.00123 | NA | |
134 | hsa-miR-543 | CHMP2B | -0.29 | 0.65642 | -0.04 | 0.98959 | miRanda | -0.12 | 0.00017 | NA | |
135 | hsa-miR-543 | CHMP4C | -0.29 | 0.65642 | 0.82 | 0.73264 | miRanda | -0.26 | 2.0E-5 | NA | |
136 | hsa-miR-496 | CHST4 | 0.55 | 0.60838 | -0.95 | 0.69336 | miRanda | -0.52 | 0.0004 | NA | |
137 | hsa-miR-496 | CLCN1 | 0.55 | 0.60838 | 0.85 | 0.48863 | miRanda | -0.43 | 0.00135 | NA | |
138 | hsa-miR-496 | CLDN1 | 0.55 | 0.60838 | -0.78 | 0.83062 | miRanda | -0.27 | 0.00195 | NA | |
139 | hsa-miR-496 | CLDN18 | 0.55 | 0.60838 | 0.1 | 0.98095 | miRanda | -1.06 | 3.0E-5 | NA | |
140 | hsa-miR-543 | CLDN18 | -0.29 | 0.65642 | 0.1 | 0.98095 | miRanda | -1.29 | 0 | NA | |
141 | hsa-miR-496 | CLDN23 | 0.55 | 0.60838 | -0.07 | 0.9754 | miRanda | -0.36 | 1.0E-5 | NA | |
142 | hsa-miR-375 | CLEC2B | 3.94 | 0.60651 | -1.28 | 0.50089 | miRanda | -0.13 | 8.0E-5 | NA | |
143 | hsa-miR-543 | CLINT1 | -0.29 | 0.65642 | -0.03 | 0.99402 | miRanda | -0.11 | 0.00602 | NA | |
144 | hsa-miR-543 | CMPK1 | -0.29 | 0.65642 | -0.13 | 0.97342 | miRanda | -0.1 | 0.00241 | NA | |
145 | hsa-miR-543 | CMTM1 | -0.29 | 0.65642 | 0.23 | 0.89004 | miRanda | -0.14 | 0.01418 | NA | |
146 | hsa-miR-543 | CMTM6 | -0.29 | 0.65642 | -0.27 | 0.94028 | miRanda | -0.1 | 0.00755 | NA | |
147 | hsa-miR-543 | CNIH4 | -0.29 | 0.65642 | 0.43 | 0.87155 | miRanda | -0.1 | 0.00047 | NA | |
148 | hsa-miR-496 | COL10A1 | 0.55 | 0.60838 | -1.68 | 0.64948 | miRanda | -0.46 | 0.00178 | NA | |
149 | hsa-miR-543 | COL10A1 | -0.29 | 0.65642 | -1.68 | 0.64948 | miRanda | -0.69 | 1.0E-5 | NA | |
150 | hsa-miR-543 | COL11A1 | -0.29 | 0.65642 | -1.22 | 0.73189 | miRanda | -0.86 | 2.0E-5 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | TISSUE DEVELOPMENT | 136 | 1518 | 1.578e-24 | 7.343e-21 |
2 | EPITHELIUM DEVELOPMENT | 89 | 945 | 2.167e-17 | 2.556e-14 |
3 | EMBRYO DEVELOPMENT | 86 | 894 | 2.197e-17 | 2.556e-14 |
4 | ORGAN MORPHOGENESIS | 83 | 841 | 1.838e-17 | 2.556e-14 |
5 | TISSUE MORPHOGENESIS | 56 | 533 | 3.375e-13 | 3.14e-10 |
6 | REGULATION OF CELL PROLIFERATION | 108 | 1496 | 6.63e-13 | 5.142e-10 |
7 | EMBRYONIC MORPHOGENESIS | 55 | 539 | 1.801e-12 | 1.197e-09 |
8 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 120 | 1791 | 4.492e-12 | 2.613e-09 |
9 | EMBRYONIC ORGAN DEVELOPMENT | 45 | 406 | 1.269e-11 | 6.561e-09 |
10 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 54 | 554 | 1.711e-11 | 7.962e-09 |
11 | TUBE DEVELOPMENT | 53 | 552 | 4.671e-11 | 1.976e-08 |
12 | REGULATION OF STEM CELL DIFFERENTIATION | 22 | 113 | 6.141e-11 | 2.381e-08 |
13 | RESPONSE TO CYTOKINE | 62 | 714 | 6.865e-11 | 2.457e-08 |
14 | TUBE MORPHOGENESIS | 38 | 323 | 9.053e-11 | 3.009e-08 |
15 | REPRODUCTIVE SYSTEM DEVELOPMENT | 43 | 408 | 1.851e-10 | 5.743e-08 |
16 | EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 22 | 122 | 2.917e-10 | 8.406e-08 |
17 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 117 | 1848 | 3.071e-10 | 8.406e-08 |
18 | CYTOKINE MEDIATED SIGNALING PATHWAY | 45 | 452 | 4.465e-10 | 1.154e-07 |
19 | EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 19 | 93 | 5.235e-10 | 1.282e-07 |
20 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 63 | 771 | 5.747e-10 | 1.337e-07 |
21 | IMMUNE SYSTEM PROCESS | 122 | 1984 | 7.277e-10 | 1.612e-07 |
22 | EPITHELIAL CELL DIFFERENTIATION | 47 | 495 | 8.752e-10 | 1.851e-07 |
23 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 100 | 1518 | 9.338e-10 | 1.889e-07 |
24 | MORPHOGENESIS OF AN EPITHELIUM | 41 | 400 | 1.141e-09 | 2.212e-07 |
25 | SKELETAL SYSTEM DEVELOPMENT | 44 | 455 | 1.74e-09 | 3.239e-07 |
26 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 118 | 1929 | 2.004e-09 | 3.587e-07 |
27 | CELL DIVISION | 44 | 460 | 2.44e-09 | 4.204e-07 |
28 | REGULATION OF CELL DEATH | 96 | 1472 | 3.564e-09 | 5.923e-07 |
29 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 105 | 1672 | 4.595e-09 | 7.373e-07 |
30 | POSITIVE REGULATION OF LOCOMOTION | 41 | 420 | 4.798e-09 | 7.441e-07 |
31 | GLAND DEVELOPMENT | 39 | 395 | 8.356e-09 | 1.254e-06 |
32 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 91 | 1395 | 9.536e-09 | 1.387e-06 |
33 | SKELETAL SYSTEM MORPHOGENESIS | 26 | 201 | 1.212e-08 | 1.708e-06 |
34 | POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 13 | 50 | 1.302e-08 | 1.782e-06 |
35 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 69 | 957 | 1.552e-08 | 2.064e-06 |
36 | STEM CELL DIFFERENTIATION | 25 | 190 | 1.632e-08 | 2.11e-06 |
37 | MITOTIC SISTER CHROMATID SEGREGATION | 17 | 91 | 1.769e-08 | 2.225e-06 |
38 | EMBRYONIC ORGAN MORPHOGENESIS | 31 | 279 | 1.933e-08 | 2.367e-06 |
39 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 66 | 905 | 2.108e-08 | 2.515e-06 |
40 | MITOTIC NUCLEAR DIVISION | 36 | 361 | 2.435e-08 | 2.833e-06 |
41 | POSITIVE REGULATION OF CELL COMMUNICATION | 96 | 1532 | 2.599e-08 | 2.95e-06 |
42 | REGULATION OF CELL DIFFERENTIATION | 94 | 1492 | 2.867e-08 | 3.133e-06 |
43 | LOCOMOTION | 76 | 1114 | 2.895e-08 | 3.133e-06 |
44 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 77 | 1142 | 3.813e-08 | 4.033e-06 |
45 | RESPONSE TO LIPID | 64 | 888 | 5.415e-08 | 5.599e-06 |
46 | REGULATION OF HYDROLASE ACTIVITY | 85 | 1327 | 6.99e-08 | 6.842e-06 |
47 | SISTER CHROMATID SEGREGATION | 23 | 176 | 6.928e-08 | 6.842e-06 |
48 | CELLULAR RESPONSE TO CYTOKINE STIMULUS | 49 | 606 | 7.058e-08 | 6.842e-06 |
49 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 82 | 1275 | 1.029e-07 | 9.771e-06 |
50 | CELL PROLIFERATION | 52 | 672 | 1.14e-07 | 1.039e-05 |
51 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 58 | 788 | 1.161e-07 | 1.039e-05 |
52 | CIRCULATORY SYSTEM DEVELOPMENT | 58 | 788 | 1.161e-07 | 1.039e-05 |
53 | CHROMOSOME SEGREGATION | 29 | 272 | 1.36e-07 | 1.194e-05 |
54 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 99 | 1656 | 1.513e-07 | 1.304e-05 |
55 | ENDODERM DEVELOPMENT | 14 | 71 | 1.586e-07 | 1.342e-05 |
56 | ORGANELLE FISSION | 42 | 496 | 1.793e-07 | 1.49e-05 |
57 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 86 | 1381 | 1.988e-07 | 1.623e-05 |
58 | GLAND MORPHOGENESIS | 16 | 97 | 2.819e-07 | 2.262e-05 |
59 | FORMATION OF PRIMARY GERM LAYER | 17 | 110 | 3.175e-07 | 2.504e-05 |
60 | REGULATION OF CYTOKINE PRODUCTION | 45 | 563 | 3.382e-07 | 2.575e-05 |
61 | INFLAMMATORY RESPONSE | 39 | 454 | 3.431e-07 | 2.575e-05 |
62 | IMMUNE RESPONSE | 72 | 1100 | 3.425e-07 | 2.575e-05 |
63 | DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 47 | 602 | 3.649e-07 | 2.695e-05 |
64 | POSITIVE REGULATION OF CELL DEATH | 47 | 605 | 4.209e-07 | 3.06e-05 |
65 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 66 | 983 | 4.476e-07 | 3.204e-05 |
66 | NUCLEAR CHROMOSOME SEGREGATION | 25 | 228 | 5.842e-07 | 4.119e-05 |
67 | DIGESTIVE TRACT MORPHOGENESIS | 11 | 48 | 6.922e-07 | 4.807e-05 |
68 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 103 | 1805 | 7.574e-07 | 5.135e-05 |
69 | POSITIVE REGULATION OF CELL PROLIFERATION | 57 | 814 | 7.615e-07 | 5.135e-05 |
70 | ENDODERM FORMATION | 11 | 50 | 1.073e-06 | 7.131e-05 |
71 | MESENCHYME DEVELOPMENT | 22 | 190 | 1.101e-06 | 7.216e-05 |
72 | RESPONSE TO EXTERNAL STIMULUS | 103 | 1821 | 1.138e-06 | 7.353e-05 |
73 | ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 15 | 95 | 1.179e-06 | 7.518e-05 |
74 | DIGESTIVE SYSTEM DEVELOPMENT | 19 | 148 | 1.244e-06 | 7.822e-05 |
75 | RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 30 | 321 | 1.408e-06 | 8.736e-05 |
76 | CELL DEVELOPMENT | 85 | 1426 | 1.442e-06 | 8.828e-05 |
77 | DEFENSE RESPONSE | 76 | 1231 | 1.511e-06 | 8.897e-05 |
78 | REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 8 | 25 | 1.502e-06 | 8.897e-05 |
79 | NEGATIVE REGULATION OF CELL DEATH | 59 | 872 | 1.473e-06 | 8.897e-05 |
80 | ANTERIOR POSTERIOR PATTERN SPECIFICATION | 22 | 194 | 1.567e-06 | 9.112e-05 |
81 | VASCULATURE DEVELOPMENT | 38 | 469 | 2.021e-06 | 0.0001161 |
82 | ZYMOGEN ACTIVATION | 16 | 112 | 2.066e-06 | 0.0001172 |
83 | REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 23 | 213 | 2.138e-06 | 0.0001198 |
84 | POSITIVE REGULATION OF GENE EXPRESSION | 98 | 1733 | 2.177e-06 | 0.0001205 |
85 | REGIONALIZATION | 29 | 311 | 2.202e-06 | 0.0001205 |
86 | BIOLOGICAL ADHESION | 66 | 1032 | 2.411e-06 | 0.0001304 |
87 | PATTERN SPECIFICATION PROCESS | 35 | 418 | 2.456e-06 | 0.0001313 |
88 | CRANIAL SKELETAL SYSTEM DEVELOPMENT | 11 | 55 | 2.926e-06 | 0.0001533 |
89 | REPRODUCTION | 78 | 1297 | 2.933e-06 | 0.0001533 |
90 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 65 | 1021 | 3.356e-06 | 0.0001735 |
91 | EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 10 | 46 | 3.727e-06 | 0.0001906 |
92 | CARDIAC CHAMBER MORPHOGENESIS | 15 | 104 | 3.797e-06 | 0.000192 |
93 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 64 | 1004 | 3.843e-06 | 0.0001922 |
94 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 54 | 801 | 4.627e-06 | 0.000229 |
95 | ACTIN FILAMENT BASED PROCESS | 36 | 450 | 4.995e-06 | 0.0002447 |
96 | RESPONSE TO ENDOGENOUS STIMULUS | 84 | 1450 | 5.089e-06 | 0.0002467 |
97 | MESENCHYMAL CELL DIFFERENTIATION | 17 | 134 | 5.268e-06 | 0.0002527 |
98 | REGULATION OF CHEMOTAXIS | 20 | 180 | 6.326e-06 | 0.0003004 |
99 | SENSORY ORGAN DEVELOPMENT | 38 | 493 | 6.517e-06 | 0.0003063 |
100 | CELL DEATH | 63 | 1001 | 6.887e-06 | 0.0003173 |
101 | POSITIVE REGULATION OF LEUKOCYTE MIGRATION | 15 | 109 | 6.862e-06 | 0.0003173 |
102 | RESPONSE TO ABIOTIC STIMULUS | 64 | 1024 | 7.251e-06 | 0.0003285 |
103 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 57 | 876 | 7.271e-06 | 0.0003285 |
104 | CELL MOTILITY | 55 | 835 | 7.436e-06 | 0.0003295 |
105 | LOCALIZATION OF CELL | 55 | 835 | 7.436e-06 | 0.0003295 |
106 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 19 | 167 | 7.602e-06 | 0.0003337 |
107 | ENDODERMAL CELL DIFFERENTIATION | 9 | 40 | 8.472e-06 | 0.0003684 |
108 | REGULATION OF IMMUNE SYSTEM PROCESS | 81 | 1403 | 8.647e-06 | 0.0003725 |
109 | CHROMOSOME CONDENSATION | 8 | 31 | 9.076e-06 | 0.0003737 |
110 | APPENDAGE DEVELOPMENT | 19 | 169 | 9.041e-06 | 0.0003737 |
111 | LIMB DEVELOPMENT | 19 | 169 | 9.041e-06 | 0.0003737 |
112 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 79 | 1360 | 9.051e-06 | 0.0003737 |
113 | RESPONSE TO OXIDATIVE STRESS | 30 | 352 | 9.028e-06 | 0.0003737 |
114 | POSITIVE REGULATION OF DNA REPLICATION | 13 | 86 | 9.89e-06 | 0.0004001 |
115 | TAXIS | 36 | 464 | 9.855e-06 | 0.0004001 |
116 | REGULATION OF CELL CYCLE | 60 | 949 | 1.002e-05 | 0.0004019 |
117 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 26 | 285 | 1.081e-05 | 0.0004234 |
118 | HEART DEVELOPMENT | 36 | 466 | 1.083e-05 | 0.0004234 |
119 | OSSIFICATION | 24 | 251 | 1.07e-05 | 0.0004234 |
120 | EPIDERMIS DEVELOPMENT | 24 | 253 | 1.223e-05 | 0.0004742 |
121 | POSITIVE REGULATION OF TRANSPORT | 59 | 936 | 1.302e-05 | 0.0005007 |
122 | CARDIAC CHAMBER DEVELOPMENT | 17 | 144 | 1.392e-05 | 0.0005308 |
123 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 47 | 689 | 1.434e-05 | 0.0005425 |
124 | EPITHELIAL CELL PROLIFERATION | 13 | 89 | 1.449e-05 | 0.0005439 |
125 | REGULATION OF ORGAN MORPHOGENESIS | 23 | 242 | 1.792e-05 | 0.0006669 |
126 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 37 | 498 | 1.939e-05 | 0.0007161 |
127 | ODONTOGENESIS | 14 | 105 | 1.994e-05 | 0.0007304 |
128 | REGULATION OF CELL CYCLE PROCESS | 40 | 558 | 2.056e-05 | 0.0007474 |
129 | EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 5 | 11 | 2.12e-05 | 0.0007647 |
130 | REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 11 | 67 | 2.137e-05 | 0.0007647 |
131 | POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 55 | 867 | 2.159e-05 | 0.000767 |
132 | REGULATION OF LEUKOCYTE MIGRATION | 17 | 149 | 2.184e-05 | 0.0007698 |
133 | HEART MORPHOGENESIS | 21 | 212 | 2.215e-05 | 0.0007748 |
134 | POSITIVE REGULATION OF CHEMOTAXIS | 15 | 120 | 2.232e-05 | 0.0007749 |
135 | REGULATION OF CYTOSKELETON ORGANIZATION | 37 | 502 | 2.307e-05 | 0.000795 |
136 | REGULATION OF DNA BINDING | 13 | 93 | 2.35e-05 | 0.0008041 |
137 | POSITIVE REGULATION OF CELL CYCLE PROCESS | 23 | 247 | 2.485e-05 | 0.000844 |
138 | RESPONSE TO WOUNDING | 40 | 563 | 2.518e-05 | 0.0008489 |
139 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 57 | 917 | 2.723e-05 | 0.0009116 |
140 | REGULATION OF PEPTIDASE ACTIVITY | 31 | 392 | 2.806e-05 | 0.000926 |
141 | SEX DIFFERENTIATION | 24 | 266 | 2.799e-05 | 0.000926 |
142 | REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 17 | 153 | 3.083e-05 | 0.00101 |
143 | REGULATION OF CELL ADHESION | 43 | 629 | 3.154e-05 | 0.001026 |
144 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 42 | 609 | 3.181e-05 | 0.001028 |
145 | POSITIVE REGULATION OF PEPTIDASE ACTIVITY | 17 | 154 | 3.354e-05 | 0.001076 |
146 | REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 57 | 926 | 3.578e-05 | 0.001136 |
147 | REGULATION OF CELLULAR PROTEIN LOCALIZATION | 39 | 552 | 3.588e-05 | 0.001136 |
148 | GASTRULATION | 17 | 155 | 3.645e-05 | 0.001146 |
149 | RESPONSE TO BIOTIC STIMULUS | 55 | 886 | 3.914e-05 | 0.001222 |
150 | NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 13 | 98 | 4.138e-05 | 0.001284 |
151 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 48 | 740 | 4.193e-05 | 0.001292 |
152 | REGULATION OF SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM | 20 | 205 | 4.288e-05 | 0.001313 |
153 | BLOOD VESSEL MORPHOGENESIS | 29 | 364 | 4.415e-05 | 0.001334 |
154 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 82 | 1492 | 4.417e-05 | 0.001334 |
155 | MITOTIC CELL CYCLE | 49 | 766 | 4.951e-05 | 0.001486 |
156 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 49 | 767 | 5.115e-05 | 0.001526 |
157 | TUBE FORMATION | 15 | 129 | 5.26e-05 | 0.001559 |
158 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 87 | 1618 | 5.575e-05 | 0.001642 |
159 | POSITIVE REGULATION OF CELL CYCLE | 27 | 332 | 5.654e-05 | 0.001655 |
160 | POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 25 | 296 | 5.74e-05 | 0.001669 |
161 | REGULATION OF DNA REPLICATION | 17 | 161 | 5.915e-05 | 0.00171 |
162 | ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 11 | 75 | 6.302e-05 | 0.001799 |
163 | BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 15 | 131 | 6.291e-05 | 0.001799 |
164 | CELL CHEMOTAXIS | 17 | 162 | 6.396e-05 | 0.001815 |
165 | REGULATION OF MITOTIC CELL CYCLE | 34 | 468 | 6.529e-05 | 0.001841 |
166 | CARTILAGE DEVELOPMENT | 16 | 147 | 6.722e-05 | 0.001884 |
167 | POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING | 18 | 179 | 6.897e-05 | 0.001922 |
168 | REGULATION OF MUSCLE TISSUE DEVELOPMENT | 13 | 103 | 7.012e-05 | 0.001931 |
169 | REGULATION OF MUSCLE ORGAN DEVELOPMENT | 13 | 103 | 7.012e-05 | 0.001931 |
170 | WOUND HEALING | 34 | 470 | 7.098e-05 | 0.001943 |
171 | REGULATION OF GTPASE ACTIVITY | 44 | 673 | 7.285e-05 | 0.001982 |
172 | MUSCLE STRUCTURE DEVELOPMENT | 32 | 432 | 7.395e-05 | 0.002001 |
173 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 51 | 823 | 7.822e-05 | 0.002104 |
174 | OUTFLOW TRACT SEPTUM MORPHOGENESIS | 5 | 14 | 8.408e-05 | 0.002249 |
175 | RESPONSE TO TUMOR NECROSIS FACTOR | 21 | 233 | 8.847e-05 | 0.002352 |
176 | DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 20 | 216 | 8.925e-05 | 0.002359 |
177 | POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 28 | 360 | 9.012e-05 | 0.002369 |
178 | REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 9 | 53 | 9.105e-05 | 0.00238 |
179 | NEGATIVE REGULATION OF MULTI ORGANISM PROCESS | 16 | 151 | 9.277e-05 | 0.002411 |
180 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 93 | 1784 | 9.459e-05 | 0.002445 |
181 | REGULATION OF NIK NF KAPPAB SIGNALING | 8 | 42 | 9.627e-05 | 0.002475 |
182 | CELLULAR RESPONSE TO OXIDATIVE STRESS | 18 | 184 | 9.852e-05 | 0.002519 |
183 | RESPONSE TO ESTROGEN | 20 | 218 | 0.0001013 | 0.002577 |
184 | POSITIVE REGULATION OF DNA METABOLIC PROCESS | 18 | 185 | 0.0001056 | 0.002671 |
185 | REGULATION OF CELL DIVISION | 23 | 272 | 0.0001102 | 0.002772 |
186 | PLACENTA DEVELOPMENT | 15 | 138 | 0.0001143 | 0.002858 |
187 | POSITIVE REGULATION OF KINASE ACTIVITY | 34 | 482 | 0.0001156 | 0.002877 |
188 | REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 9 | 55 | 0.0001227 | 0.00302 |
189 | MORPHOGENESIS OF AN EPITHELIAL FOLD | 5 | 15 | 0.0001225 | 0.00302 |
190 | IN UTERO EMBRYONIC DEVELOPMENT | 25 | 311 | 0.0001265 | 0.003097 |
191 | EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 7 | 33 | 0.0001293 | 0.003133 |
192 | POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 11 | 81 | 0.0001287 | 0.003133 |
193 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 15 | 140 | 0.0001344 | 0.00324 |
194 | BODY MORPHOGENESIS | 8 | 44 | 0.0001358 | 0.003258 |
195 | EPITHELIAL TO MESENCHYMAL TRANSITION | 9 | 56 | 0.0001416 | 0.003379 |
196 | REGULATION OF PROTEIN MODIFICATION PROCESS | 89 | 1710 | 0.0001433 | 0.003403 |
197 | REGULATION OF LEUKOCYTE CHEMOTAXIS | 12 | 96 | 0.000145 | 0.003426 |
198 | POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 6 | 24 | 0.0001502 | 0.003529 |
199 | REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 23 | 278 | 0.0001525 | 0.003548 |
200 | CELL CYCLE | 72 | 1316 | 0.000152 | 0.003548 |
201 | INTRACELLULAR SIGNAL TRANSDUCTION | 83 | 1572 | 0.0001536 | 0.003555 |
202 | ACTIN FILAMENT ORGANIZATION | 17 | 174 | 0.0001548 | 0.003566 |
203 | NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 28 | 372 | 0.000157 | 0.003598 |
204 | POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 7 | 34 | 0.0001579 | 0.0036 |
205 | SPROUTING ANGIOGENESIS | 8 | 45 | 0.0001601 | 0.003634 |
206 | NEGATIVE REGULATION OF CELL CYCLE | 31 | 433 | 0.0001759 | 0.003973 |
207 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 40 | 616 | 0.0001772 | 0.003983 |
208 | POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 35 | 514 | 0.0001826 | 0.004086 |
209 | RESPONSE TO INTERFERON GAMMA | 15 | 144 | 0.0001841 | 0.0041 |
210 | LUNG CELL DIFFERENTIATION | 6 | 25 | 0.0001917 | 0.004228 |
211 | SKIN DEVELOPMENT | 19 | 211 | 0.0001909 | 0.004228 |
212 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 20 | 229 | 0.0001974 | 0.004333 |
213 | NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 43 | 684 | 0.0002078 | 0.00454 |
214 | RESPONSE TO ESTRADIOL | 15 | 146 | 0.0002145 | 0.004664 |
215 | REGULATION OF CELL DEVELOPMENT | 50 | 836 | 0.0002157 | 0.004668 |
216 | RESPONSE TO INORGANIC SUBSTANCE | 33 | 479 | 0.000224 | 0.004818 |
217 | EXTRACELLULAR STRUCTURE ORGANIZATION | 24 | 304 | 0.0002247 | 0.004818 |
218 | REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 7 | 36 | 0.0002303 | 0.004917 |
219 | MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION | 11 | 87 | 0.0002455 | 0.004967 |
220 | ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION | 11 | 87 | 0.0002455 | 0.004967 |
221 | EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS | 5 | 17 | 0.0002379 | 0.004967 |
222 | VIRAL ENTRY INTO HOST CELL | 11 | 87 | 0.0002455 | 0.004967 |
223 | ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION | 11 | 87 | 0.0002455 | 0.004967 |
224 | CHONDROCYTE DIFFERENTIATION | 9 | 60 | 0.0002437 | 0.004967 |
225 | FEMALE SEX DIFFERENTIATION | 13 | 116 | 0.0002369 | 0.004967 |
226 | TISSUE REMODELING | 11 | 87 | 0.0002455 | 0.004967 |
227 | MOVEMENT IN HOST ENVIRONMENT | 11 | 87 | 0.0002455 | 0.004967 |
228 | ENTRY INTO HOST | 11 | 87 | 0.0002455 | 0.004967 |
229 | RESPONSE TO ALCOHOL | 27 | 362 | 0.0002366 | 0.004967 |
230 | ENTRY INTO HOST CELL | 11 | 87 | 0.0002455 | 0.004967 |
231 | POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 14 | 132 | 0.0002477 | 0.004974 |
232 | RESPONSE TO TRANSITION METAL NANOPARTICLE | 15 | 148 | 0.0002491 | 0.004974 |
233 | REGULATION OF VASCULATURE DEVELOPMENT | 20 | 233 | 0.0002484 | 0.004974 |
234 | REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT | 8 | 48 | 0.0002553 | 0.005055 |
235 | REGULATION OF ORGANELLE ORGANIZATION | 65 | 1178 | 0.0002545 | 0.005055 |
236 | MAMMARY GLAND DEVELOPMENT | 13 | 117 | 0.000258 | 0.005087 |
237 | EYE DEVELOPMENT | 25 | 326 | 0.0002617 | 0.005139 |
238 | REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 27 | 365 | 0.0002699 | 0.005277 |
239 | REGULATION OF STEM CELL PROLIFERATION | 11 | 88 | 0.0002718 | 0.005291 |
240 | CHROMOSOME LOCALIZATION | 9 | 61 | 0.000277 | 0.005326 |
241 | DIGESTIVE SYSTEM PROCESS | 9 | 61 | 0.000277 | 0.005326 |
242 | NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 7 | 37 | 0.0002755 | 0.005326 |
243 | MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 14 | 134 | 0.0002897 | 0.005547 |
244 | POSITIVE REGULATION OF NEUTROPHIL MIGRATION | 6 | 27 | 0.0003017 | 0.005705 |
245 | RESPONSE TO BACTERIUM | 35 | 528 | 0.0003028 | 0.005705 |
246 | REGULATION OF VIRAL GENOME REPLICATION | 10 | 75 | 0.0003012 | 0.005705 |
247 | NEURAL CREST CELL DIFFERENTIATION | 10 | 75 | 0.0003012 | 0.005705 |
248 | CARDIAC VENTRICLE MORPHOGENESIS | 9 | 62 | 0.000314 | 0.005892 |
249 | CELL JUNCTION ORGANIZATION | 17 | 185 | 0.0003219 | 0.006015 |
250 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 24 | 312 | 0.0003296 | 0.006135 |
251 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 57 | 1008 | 0.000335 | 0.006211 |
252 | MUSCLE TISSUE DEVELOPMENT | 22 | 275 | 0.0003367 | 0.006217 |
253 | REGULATION OF MULTI ORGANISM PROCESS | 32 | 470 | 0.0003412 | 0.006276 |
254 | RESPONSE TO METAL ION | 25 | 333 | 0.0003603 | 0.006542 |
255 | NEGATIVE REGULATION OF MOLECULAR FUNCTION | 60 | 1079 | 0.0003613 | 0.006542 |
256 | NEUROGENESIS | 74 | 1402 | 0.0003594 | 0.006542 |
257 | DEVELOPMENTAL GROWTH | 25 | 333 | 0.0003603 | 0.006542 |
258 | CELLULAR COMPONENT MORPHOGENESIS | 52 | 900 | 0.0003698 | 0.00667 |
259 | REGULATION OF KERATINOCYTE PROLIFERATION | 6 | 28 | 0.0003725 | 0.006693 |
260 | CELL CYCLE PROCESS | 60 | 1081 | 0.0003788 | 0.00678 |
261 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 58 | 1036 | 0.0003824 | 0.006791 |
262 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 58 | 1036 | 0.0003824 | 0.006791 |
263 | NEGATIVE REGULATION OF CELL ADHESION | 19 | 223 | 0.0003858 | 0.006823 |
264 | CYTOSKELETON DEPENDENT CYTOKINESIS | 7 | 39 | 0.0003871 | 0.006823 |
265 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 63 | 1152 | 0.000401 | 0.007042 |
266 | REGULATION OF BONE DEVELOPMENT | 5 | 19 | 0.0004215 | 0.007345 |
267 | REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 4 | 11 | 0.0004211 | 0.007345 |
268 | REGULATION OF PROTEIN LOCALIZATION | 54 | 950 | 0.0004235 | 0.007353 |
269 | RESPONSE TO STEROID HORMONE | 33 | 497 | 0.0004331 | 0.007491 |
270 | STRIATED MUSCLE CELL DIFFERENTIATION | 16 | 173 | 0.0004445 | 0.007661 |
271 | POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT | 6 | 29 | 0.0004558 | 0.007826 |
272 | RESPONSE TO REACTIVE OXYGEN SPECIES | 17 | 191 | 0.0004666 | 0.007982 |
273 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 47 | 799 | 0.0004776 | 0.00814 |
274 | CELL FATE COMMITMENT | 19 | 227 | 0.0004812 | 0.008171 |
275 | REGULATION OF DNA METABOLIC PROCESS | 25 | 340 | 0.0004903 | 0.008296 |
276 | REGULATION OF CELLULAR LOCALIZATION | 68 | 1277 | 0.0004932 | 0.008315 |
277 | MESODERM MORPHOGENESIS | 9 | 66 | 0.0005053 | 0.008489 |
278 | CELLULAR RESPONSE TO MECHANICAL STIMULUS | 10 | 80 | 0.0005106 | 0.008547 |
279 | EPIDERMAL CELL DIFFERENTIATION | 14 | 142 | 0.0005248 | 0.008752 |
280 | PROSTATE GLAND DEVELOPMENT | 7 | 41 | 0.0005322 | 0.008844 |
281 | CONNECTIVE TISSUE DEVELOPMENT | 17 | 194 | 0.0005579 | 0.009238 |
282 | COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 12 | 111 | 0.0005659 | 0.009338 |
283 | REGENERATION | 15 | 161 | 0.0006139 | 0.00999 |
284 | TROPHOBLAST GIANT CELL DIFFERENTIATION | 4 | 12 | 0.0006141 | 0.00999 |
285 | REGULATION OF OSTEOBLAST DIFFERENTIATION | 12 | 112 | 0.0006139 | 0.00999 |
286 | REGULATION OF OSSIFICATION | 16 | 178 | 0.0006085 | 0.00999 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | ACTIN BINDING | 33 | 393 | 4.468e-06 | 0.001303 |
2 | CHEMOKINE ACTIVITY | 10 | 48 | 5.61e-06 | 0.001303 |
3 | CHEMOKINE RECEPTOR BINDING | 11 | 57 | 4.23e-06 | 0.001303 |
4 | MACROMOLECULAR COMPLEX BINDING | 83 | 1399 | 2.334e-06 | 0.001303 |
5 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 28 | 315 | 8.179e-06 | 0.00152 |
6 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 44 | 629 | 1.463e-05 | 0.001941 |
7 | CYTOKINE RECEPTOR BINDING | 25 | 271 | 1.313e-05 | 0.001941 |
8 | RECEPTOR BINDING | 83 | 1476 | 1.75e-05 | 0.002033 |
9 | PROTEIN DOMAIN SPECIFIC BINDING | 43 | 624 | 2.614e-05 | 0.002698 |
10 | PROTEIN KINASE C BINDING | 9 | 50 | 5.659e-05 | 0.005257 |
11 | PROTEIN COMPLEX BINDING | 56 | 935 | 8.747e-05 | 0.007388 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | MEMBRANE MICRODOMAIN | 31 | 288 | 4.049e-08 | 1.182e-05 |
2 | MEMBRANE REGION | 77 | 1134 | 2.84e-08 | 1.182e-05 |
3 | CELL SURFACE | 56 | 757 | 1.642e-07 | 3.197e-05 |
4 | CONDENSED CHROMOSOME OUTER KINETOCHORE | 6 | 12 | 1.484e-06 | 0.0002166 |
5 | ANCHORING JUNCTION | 39 | 489 | 2.18e-06 | 0.0002546 |
6 | CELL SUBSTRATE JUNCTION | 33 | 398 | 5.842e-06 | 0.0005686 |
7 | EXTRACELLULAR SPACE | 80 | 1376 | 7.653e-06 | 0.0006385 |
8 | APICAL PART OF CELL | 30 | 361 | 1.473e-05 | 0.0009561 |
9 | INTRINSIC COMPONENT OF PLASMA MEMBRANE | 91 | 1649 | 1.381e-05 | 0.0009561 |
10 | PLASMA MEMBRANE REGION | 58 | 929 | 2.038e-05 | 0.001107 |
11 | CONDENSED CHROMOSOME | 20 | 195 | 2.085e-05 | 0.001107 |
12 | CHROMOSOME CENTROMERIC REGION | 18 | 174 | 4.754e-05 | 0.002314 |
13 | ACTIN CYTOSKELETON | 33 | 444 | 5.37e-05 | 0.002413 |
14 | TRANSCRIPTION FACTOR COMPLEX | 24 | 298 | 0.0001666 | 0.006949 |
15 | PHAGOCYTIC VESICLE MEMBRANE | 9 | 58 | 0.0001869 | 0.007277 |
16 | CELL JUNCTION | 64 | 1151 | 0.0002306 | 0.008417 |
17 | MIDBODY | 14 | 132 | 0.0002477 | 0.008508 |
18 | EXTRACELLULAR MATRIX | 30 | 426 | 0.0002947 | 0.009561 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | TNF_signaling_pathway_hsa04668 | 17 | 108 | 2.42e-07 | 1.259e-05 | |
2 | p53_signaling_pathway_hsa04115 | 13 | 68 | 6.399e-07 | 1.664e-05 | |
3 | Cytokine_cytokine_receptor_interaction_hsa04060 | 26 | 270 | 4.081e-06 | 7.074e-05 | |
4 | Apoptosis_hsa04210 | 16 | 138 | 3.1e-05 | 0.000403 | |
5 | Adherens_junction_hsa04520 | 10 | 72 | 0.0002143 | 0.002228 | |
6 | MAPK_signaling_pathway_hsa04010 | 23 | 295 | 0.0003599 | 0.003119 | |
7 | Necroptosis_hsa04217 | 14 | 164 | 0.002126 | 0.01579 | |
8 | Ferroptosis_hsa04216 | 6 | 40 | 0.002648 | 0.0171 | |
9 | Tight_junction_hsa04530 | 14 | 170 | 0.002959 | 0.0171 | |
10 | Apoptosis_multiple_species_hsa04215 | 5 | 33 | 0.005717 | 0.02973 | |
11 | Regulation_of_actin_cytoskeleton_hsa04810 | 15 | 208 | 0.007345 | 0.03472 | |
12 | Hippo_signaling_pathway_hsa04390 | 12 | 154 | 0.008745 | 0.03789 | |
13 | Focal_adhesion_hsa04510 | 14 | 199 | 0.01153 | 0.04324 | |
14 | Cellular_senescence_hsa04218 | 12 | 160 | 0.01164 | 0.04324 | |
15 | Ras_signaling_pathway_hsa04014 | 15 | 232 | 0.01852 | 0.05961 | |
16 | NF_kappa_B_signaling_pathway_hsa04064 | 8 | 95 | 0.0194 | 0.05961 | |
17 | Phagosome_hsa04145 | 11 | 152 | 0.01949 | 0.05961 | |
18 | ECM_receptor_interaction_hsa04512 | 7 | 82 | 0.02606 | 0.0717 | |
19 | PI3K_Akt_signaling_pathway_hsa04151 | 20 | 352 | 0.02622 | 0.0717 | |
20 | Endocytosis_hsa04144 | 15 | 244 | 0.02758 | 0.0717 | |
21 | Rap1_signaling_pathway_hsa04015 | 13 | 206 | 0.0321 | 0.07949 | |
22 | Cell_adhesion_molecules_.CAMs._hsa04514 | 9 | 145 | 0.07275 | 0.1701 | |
23 | Wnt_signaling_pathway_hsa04310 | 9 | 146 | 0.07524 | 0.1701 | |
24 | Hippo_signaling_pathway_multiple_species_hsa04392 | 3 | 29 | 0.08176 | 0.1771 | |
25 | FoxO_signaling_pathway_hsa04068 | 8 | 132 | 0.097 | 0.2018 | |
26 | Lysosome_hsa04142 | 7 | 123 | 0.1465 | 0.2929 | |
27 | Gap_junction_hsa04540 | 5 | 88 | 0.2013 | 0.3876 | |
28 | Phospholipase_D_signaling_pathway_hsa04072 | 7 | 146 | 0.26 | 0.4829 | |
29 | Cell_cycle_hsa04110 | 6 | 124 | 0.2761 | 0.4858 | |
30 | HIF_1_signaling_pathway_hsa04066 | 5 | 100 | 0.2803 | 0.4858 | |
31 | TGF_beta_signaling_pathway_hsa04350 | 4 | 84 | 0.3467 | 0.5426 | |
32 | VEGF_signaling_pathway_hsa04370 | 3 | 59 | 0.3477 | 0.5426 | |
33 | Jak_STAT_signaling_pathway_hsa04630 | 7 | 162 | 0.3502 | 0.5426 | |
34 | ErbB_signaling_pathway_hsa04012 | 4 | 85 | 0.3548 | 0.5426 | |
35 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 6 | 139 | 0.3698 | 0.5494 | |
36 | cAMP_signaling_pathway_hsa04024 | 8 | 198 | 0.4026 | 0.5816 | |
37 | Calcium_signaling_pathway_hsa04020 | 7 | 182 | 0.466 | 0.652 | |
38 | ABC_transporters_hsa02010 | 2 | 45 | 0.4765 | 0.652 | |
39 | Notch_signaling_pathway_hsa04330 | 2 | 48 | 0.5107 | 0.6809 | |
40 | Peroxisome_hsa04146 | 3 | 83 | 0.5671 | 0.7373 | |
41 | Sphingolipid_signaling_pathway_hsa04071 | 4 | 118 | 0.605 | 0.7673 | |
42 | Oocyte_meiosis_hsa04114 | 4 | 124 | 0.6439 | 0.7958 | |
43 | Autophagy_animal_hsa04140 | 4 | 128 | 0.6684 | 0.7958 | |
44 | Mitophagy_animal_hsa04137 | 2 | 65 | 0.6753 | 0.7958 | |
45 | cGMP_PKG_signaling_pathway_hsa04022 | 5 | 163 | 0.6886 | 0.7958 | |
46 | mTOR_signaling_pathway_hsa04150 | 4 | 151 | 0.7863 | 0.8846 | |
47 | AMPK_signaling_pathway_hsa04152 | 3 | 121 | 0.8066 | 0.8846 | |
48 | Neuroactive_ligand_receptor_interaction_hsa04080 | 7 | 278 | 0.8659 | 0.9047 | |
49 | Phosphatidylinositol_signaling_system_hsa04070 | 2 | 99 | 0.8699 | 0.9047 | |
50 | Apelin_signaling_pathway_hsa04371 | 2 | 137 | 0.9573 | 0.976 |